There have been several cases around the world in which Tranexamic acid has been administered intrathecally in error instead of the local anaesthetic agent, bupivacaine.(1) Postpartum haemorrhage is the third most common cause of death in obstetric practice in developing countries. Tranexamic acid is life-saving in...
Pretoria, 19 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is aware of the product Lubri-A (Sterile Lubricating Jelly) manufactured by Electro-Spyres, classified as Class B medical device and currently being distributed across the country. SAHPRA has been informed of multiple complaints received...
The South African Health Products Regulatory Authority (SAHPRA) has launched its very own chatbot, Reggie. Reggie is here to help you find information on the website more easily. How do you use the chatbot?Simply type in a keyword or ask Reggie a question. He is quick...
The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and tThe Department of Pharmacy and Pharmacology at the University of Witwatersrand, is pleased to announce the second cohort of graduates who successfully completed the short course for Clinical Assessors within African...
The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and tThe Department of Pharmacy and Pharmacology at the University of Witwatersrand, is pleased to announce the second cohort of graduates who successfully completed the short course for Clinical Assessors within African...
Every year, the world commemorates World Tuberculosis (TB) Day on 24 March to raise awareness of the impact of the disease for one’s health as well as social and economic consequences. ...
1 March 2023 The COVID-19 pandemic turned the spotlight on the South African Health Products Regulator (SAHPRA), with many people expecting the regulator to approve medication that would see the end to the virus, but more often with limited understanding of the processes involved in reaching...
24 February 2023 The Radiation Control Unit of the South African Health Products Regulatory Authority (SAHPRA)hosted an engagement with Inspection Bodies. We have invited several Inspection Bodies to share their knowledge, experience, and expertise to begin this conversation focusing on the: Accreditation process by the South African National Accreditation...
09 January 2023 Note to Radionuclides Authority Holders The Annual Returns have been somewhat delayed and are now being sent out. It is a time-consuming process and will not be completed before 21 January 2023. Please await the prepopulated form for year-end 2022 (AR22) and do not resort...
Pretoria, 2 December 2022 – The South African Health Products Regulatory Authority (SAHPRA) has registered Cabotegravir (Apretude 600 mg/3ml injection), a long-acting HIV pre-exposure prophylactic. Cabotegravir is an antiretroviral drug (ARV) that people living with HIV may use, together with other ARVs, to keep the virus...
